Olaparib Dose Escalating Trial + Concurrent RT With or Without Cisplatin in Locally Advanced Non-small Cell Lung Carcinoma
by on Saturday, March 24th, 2012 | No Comments
Condition: NSCLC
Interventions: Drug: Olaparib; Drug: Cisplatin; Radiation: Radiation
Sponsors: The Netherlands Cancer Institute; AstraZeneca
Not yet recruiting – verified March 2012